Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kantarci, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kantarci, O.
NEUROLOGY 1998;51:765-772
© 1998 American Academy of Neurology

Survival and predictors of disability in Turkish MS patients

O. Kantarci, MD, A. Siva, MD, M. Eraksoy, MD, R. Karabudak, MD, N. Sütlas, MD, J. Agaoglu, MD, F. Turan, M. Özmenoglu, MD, E. Togrul, MD, M. Demirkiran, MD and The Turkish Multiple Sclerosis Study Group (TUMSSG)*

From the Department of Neurology (Drs. Kantarci and Siva), Istanbul University, Cerrahpasa School of Medicine; the Department of Neurology(Dr. Eraksoy), Istanbul University, Istanbul Medical School; the Department of Neurology (Dr. Karabudak), Hacettepe University Medical School, Ankara; the Department of Neurology (Dr. Sütlas), Bakirköy State Hospital for Mental and Neurological Illnesses, Istanbul; the Department of Neurology(Dr. Agaoglu), Okmeydani Social Security Hospital, Istanbul; the Department of Neurology (Dr. Turan), Uludag University Medical School, Bursa; the Department of Neurology (Dr. Özmenoglu), Karadeniz Technical University Medical School, Trabzon; the Department of Neurology (Dr. Togrul), Gülhane Military Academy of Medicine, Istanbul; and the Department of Neurology (Dr. Demirkiran), Çukurova University Medical School, Adana.

Address correspondence and reprint requests to Dr. Aksel Siva, Hac1 Emin Sok. 20/7 Nisantas1, 80200, Istanbul, Turkey.

Objective: To examine the natural history, survival, and prognostic factors in a sample of Turkish MS patients.

Method: This multicenter study included 1,259 definite MS patients diagnosed according to the criteria of Poser et al. Actuarial analysis of selected disability levels of 3, 6, 8, and 10 achieved with the Expanded Disability Status Scale (EDSS); a multivariate Cox regression analysis for prognostic factors related to time to reach EDSS ≥ 6; and Pearson's correlation coefficient for individual factors were performed.

Results: The survival (±SE) at 15 years from onset was 94.6 ± 2.9%, and at 25 years was 89.0 ± 5.8%. The disability reached by 15 years was EDSS ≥ 3 in 66.4%, EDSS ≥ 6 in 41.2%, EDSS ≥ 8 in 10.5%, and EDSS = 10 in 5.4%. The most significant unfavorable prognostic factors were progressive course (relative risk [RR], 3.73; CI, 2.71 to 5.13) and sphincter symptoms at onset (RR, 1.86; CI, 1.23 to 2.82), followed by male sex, motor symptoms at onset, and a high attack frequency within the first 5 years. Primary progressive disease was correlated positively with male sex (r = 0.0895, p = 0.001), older age (r = 0.1807, p = 0.000), and motor (r = 0.1433, p = 0.000) or sphincter symptoms (r = 0.1001, p = 0.000) at onset, unlike relapsing-remitting and secondary progressive disease.

Conclusions: Although a slightly better prognosis is observed in the Turkish MS population, early prognostic factors are similar to most of the previous Western series. Primary progressive disease, mostly seen in older men with motor and sphincter involvement at onset, has a worse prognosis and may represent a distinct behavioral variant of MS.


*See the Appendix on page 772 for a listing of the investigators of the Turkish Multiple Sclerosis Study Group and their affiliations.

Supported in part by the Turkish Multiple Sclerosis Society.

Presented in part at the 13th ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) Congress; Istanbul, Turkey; November 1997; and awarded as one of the two best presentations by the scientific committee of ECTRIMS.

Received January 28, 1998. Accepted in final form May 15, 1998.




This article has been cited by other articles:


Home page
Mult SclerHome page
R Antulov, B Weinstock-Guttman, J. Cox, S Hussein, J Durfee, C Caiola, M. Dwyer, N Bergsland, N Abdelrahman, M Stosic, et al.
Gender-related differences in MS: a study of conventional and nonconventional MRI measures
Multiple Sclerosis, March 1, 2009; 15(3): 345 - 354.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Debouverie, L Laforest, E Van Ganse, F Guillemin, and for the LORSEP Group
Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients
Multiple Sclerosis, February 1, 2009; 15(2): 251 - 257.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Hirst, G Ingram, R Swingler, D A S Compston, T Pickersgill, and N P Robertson
Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Hirst, R Swingler, D A S Compston, Y Ben-Shlomo, and N P Robertson
Survival and cause of death in multiple sclerosis: a prospective population-based study
J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1016 - 1021.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
E. Leray, S. Morrissey, J. Yaouanq, M. Coustans, E. Le Page, J. Chaperon, and G. Edan
Long-term survival of patients with multiple sclerosis in West France
Multiple Sclerosis, August 1, 2007; 13(7): 865 - 874.
[Abstract] [PDF]


Home page
Arch NeurolHome page
A. Langer-Gould, R. A. Popat, S. M. Huang, K. Cobb, P. Fontoura, M. K. Gould, and L. M. Nelson
Clinical and Demographic Predictors of Long-term Disability in Patients With Relapsing-Remitting Multiple Sclerosis: A Systematic Review
Arch Neurol, December 1, 2006; 63(12): 1686 - 1691.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. H. Kantarci, L. F. Barcellos, E. J. Atkinson, P. P. Ramsay, R. Lincoln, S. J. Achenbach, M. De Andrade, S. L. Hauser, and B. G. Weinshenker
Men transmit MS more often to their children vs women: the Carter effect.
Neurology, July 25, 2006; 67(2): 305 - 310.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. Confavreux and S. Vukusic
Age at disability milestones in multiple sclerosis
Brain, March 1, 2006; 129(3): 595 - 605.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. Bronnum-Hansen, N. Koch-Henriksen, and E. Stenager
Trends in survival and cause of death in Danish patients with multiple sclerosis
Brain, April 1, 2004; 127(4): 844 - 850.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
S. Tuzun, A. AltWntas, I. Karacan, S. Tangurek, S. Saip, and A. Siva
Bone status in multiple sclerosis: beyond corticosteroids
Multiple Sclerosis, December 1, 2003; 9(6): 600 - 604.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Eriksson, O. Andersen, and B. Runmarker
Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis
Multiple Sclerosis, June 1, 2003; 9(3): 260 - 274.
[Abstract] [PDF]


Home page
BrainHome page
C. Confavreux, S. Vukusic, and P. Adeleine
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process
Brain, April 1, 2003; 126(4): 770 - 782.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. L. Simone, D. Carrara, C. Tortorella, M. Liguori, V. Lepore, F. Pellegrini, A. Bellacosa, A. Ceccarelli, I. Pavone, and P. Livrea
Course and prognosis in early-onset MS: Comparison with adult-onset forms
Neurology, December 24, 2002; 59(12): 1922 - 1928.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
J. S. Burks, B. G. Arnason, P. K. Coyle, C. C. Ford, A. Noronha, and K. W. Rammohan
Issues and Practices in Multiple Sclerosis
Neurorehabil Neural Repair, December 1, 2002; 16(4): 307 - 320.
[Abstract] [PDF]


Home page
NeurologyHome page
J. Chapman, S. Vinokurov, A. Achiron, D. M. Karussis, K. Mitosek-Szewczyk, M. Birnbaum, D. M. Michaelson, and A. D. Korczyn
APOE genotype is a major predictor of long-term progression of disability in MS
Neurology, February 13, 2001; 56(3): 312 - 316.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
K M Myhr, T Riise, C Vedeler, M W Nortvedt, M Gronning, R Midgard, and H I Nyland
Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension
Multiple Sclerosis, February 1, 2001; 7(1): 59 - 65.
[Abstract] [PDF]


Home page
BrainHome page
M. T. Wallin, W. F. Page, and J. F. Kurtzke
Epidemiology of multiple sclerosis in US veterans VIII. Long-term survival after onset of multiple sclerosis
Brain, August 1, 2000; 123(8): 1677 - 1687.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
B. G Weinshenker
Databases in MS research: pitfalls and promises
Multiple Sclerosis, August 1, 1999; 5(4): 206 - 211.
[Abstract] [PDF]


Home page
Mult SclerHome page
Z M Levic, I Dujmovic, T Pekmezovic, M Jarebinski, J Marinkovic, N Stojsavljevic, and J Drulovic
Prognostic factors for survival in multiple sclerosis
Multiple Sclerosis, June 1, 1999; 5(3): 171 - 178.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by AAN Enterprises, Inc.